Skip to content

Drug interactions

Encorafenib + Eplerenone

Severity: Moderate

Encorafenib and Eplerenone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encorafenib has both inhibiting and inducing effects on CYP3A4, so eplerenone exposure may rise or fall unpredictably. Higher exposure raises hyperkalemia risk, whereas lower exposure reduces efficacy.

What this interaction means in plain words

Encorafenib and Eplerenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Encorafenib belongs to Oncology; Eplerenone belongs to Cardiovascular.

Evidence level: Low

Why it happens

Mixed inhibition and induction of CYP3A4 by encorafenib alters eplerenone metabolism.

What to do

Monitor serum potassium, blood pressure and clinical response when starting or stopping encorafenib. Adjust eplerenone dose accordingly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Eplerenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Encorafenib with Eplerenone?

MediHelp rates the interaction as moderate. Encorafenib and Eplerenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib has both inhibiting and inducing effects on CYP3A4, so eplerenone exposure may rise or fall unpredictably. Higher exposure raises hyperkalemia risk, whereas lower exposure reduces efficacy.

How serious is the interaction between Encorafenib and Eplerenone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium, blood pressure and clinical response when starting or stopping encorafenib. Adjust eplerenone dose accordingly.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in